Form D Explorer

Form C — EMulate Therapeutics, Inc.

0001254348-25-000003 · filed 2025-10-08 · via Wefunder Portal LLC

Offering

Target: $50,000
Maximum: $1,235,000
Security type: Common Stock
Price per security: $10.5400
Deadline: —
Oversubscription: Accepted

Issuer

Name: EMulate Therapeutics, Inc.
CIK: 1254348
Entity: Corporation
Jurisdiction: WA
Address: 2620 Bellevue Way NE
Bellevue, WA 98004
Phone: —

Most recent fiscal year financials

Total assets

$1,193,000

Cash

—

Short-term debt

$30,988,000

Long-term debt

$5,655,000

Revenues

—

COGS

—

Taxes paid

—

Net income

$-19,139,000

View original on SEC EDGAR.